Somatization in patients with predominant diarrhoea irritable bowel syndrome: the role of the intestinal barrier function and integrity

[1]  M. Neurath,et al.  Participation of the intestinal microbiota in the mechanism of beneficial effect of treatment with synbiotic Syngut on experimental colitis under stress conditions. , 2020, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[2]  S. Abdelghani,et al.  Serum Levels of Interferon Gamma INF-γ and Interleukin 10 Il-10: an Immunological Aspect among Irritable Bowel Syndrome Patients. , 2020, Pakistan Journal of Biological Sciences.

[3]  Lajia Zha,et al.  Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome , 2019, Pathogens.

[4]  T. Hendrikx,et al.  Indoles: metabolites produced by intestinal bacteria capable of controlling liver disease manifestation , 2019, Journal of internal medicine.

[5]  P. Gasparini,et al.  IBS clinical management in Italy: The AIGO survey. , 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[6]  L. Duan,et al.  Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome , 2019, Chinese medical journal.

[7]  M. Heitkemper,et al.  Multiple psychological factors predict abdominal pain severity in children with irritable bowel syndrome , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[8]  F. Russo,et al.  Adipose Tissue-Derived Biomarkers of Intestinal Barrier Functions for the Characterization of Diarrhoea-Predominant IBS , 2018, Disease markers.

[9]  F. Russo,et al.  Noninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: a case-control study , 2018, BMC Gastroenterology.

[10]  M. Trauner,et al.  A Microbial Signature of Psychological Distress in Irritable Bowel Syndrome , 2018, Psychosomatic medicine.

[11]  M. Andreucci,et al.  An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD) , 2018, European Journal of Nutrition.

[12]  S. Salvadori,et al.  The complex interplay between gastrointestinal and psychiatric symptoms in irritable bowel syndrome: A longitudinal assessment , 2018, Journal of gastroenterology and hepatology.

[13]  C. Pepine,et al.  Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression , 2017, Gut.

[14]  M. Surette,et al.  Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome. , 2017, Gastroenterology.

[15]  S. Misra,et al.  Levels of interleukins 2, 6, 8, and 10 in patients with irritable bowel syndrome , 2017, Indian journal of pathology & microbiology.

[16]  W. D. de Vos,et al.  Homeostasis of the gut barrier and potential biomarkers , 2016, American journal of physiology. Gastrointestinal and liver physiology.

[17]  Andrew H. Miller,et al.  The role of inflammation in depression: from evolutionary imperative to modern treatment target , 2015, Nature Reviews Immunology.

[18]  Swapnajeet Sahoo,et al.  Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”? , 2015, Journal of neurosciences in rural practice.

[19]  A. Serretti,et al.  Enrichment pathway analysis. The inflammatory genetic background in Bipolar Disorder. , 2015, Journal of affective disorders.

[20]  X. Zuo,et al.  Increased production of BDNF in colonic epithelial cells induced by fecal supernatants from diarrheic IBS patients , 2015, Scientific Reports.

[21]  D. Czyzewski,et al.  Are child anxiety and somatization associated with pain in pain-related functional gastrointestinal disorders? , 2015, Journal of health psychology.

[22]  E. Cereda,et al.  Increased urinary indoxyl sulfate (indican): new insights into gut dysbiosis in Parkinson's disease. , 2015, Parkinsonism & related disorders.

[23]  G. Barbara,et al.  247 Zonulin Serum Levels Are Increased in Non-Celiac Gluten Sensitivity and Irritable Bowel Syndrome With Diarrhea , 2015 .

[24]  B. Cesana,et al.  Symptom‐association probability between meal ingestion and abdominal pain in patients with irritable bowel syndrome. Does somatization play a role? , 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[25]  A. Hildenbrand,et al.  Symptom Checklist‐90‐Revised (SCL‐90‐R) , 2015 .

[26]  L. Miller.  Study design considerations for irritable bowel syndrome clinical trials , 2014, Annals of gastroenterology.

[27]  P. Henningsen,et al.  Irritable bowel syndrome: relations with functional, mental, and somatoform disorders. , 2014, World journal of gastroenterology.

[28]  C. Klein,et al.  Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. , 2014, Immunity.

[29]  F. Russo,et al.  Comparison of an enzymatic assay with liquid chromatography-pulsed amperometric detection for the determination of lactulose and mannitol in urine of healthy subjects and patients with active celiac disease , 2014, Clinical chemistry and laboratory medicine.

[30]  F. Russo,et al.  Adipokine profile in celiac patients: differences in comparison with patients suffering from diarrhea-predominant IBS and healthy subjects , 2013, Scandinavian journal of gastroenterology.

[31]  E. L. Mortensen,et al.  SCL-90-R Symptom Profiles and Outcome of Short-Term Psychodynamic Group Therapy , 2013, ISRN psychiatry.

[32]  J. Murray,et al.  Between Celiac Disease and Irritable Bowel Syndrome: The “No Man's Land” of Gluten Sensitivity , 2009, The American Journal of Gastroenterology.

[33]  P. Baldi,et al.  Dysregulation of the hypothalamic‐pituitary‐adrenal (HPA) axis in irritable bowel syndrome , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[34]  H. Eriksson,et al.  Irritable bowel syndrome subtypes differ in body awareness, psychological symptoms and biochemical stress markers. , 2008, World journal of gastroenterology.

[35]  M. Maes,et al.  The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. , 2008, Neuro endocrinology letters.

[36]  I. Wiklund,et al.  Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: A six-country study , 2008, Health and quality of life outcomes.

[37]  B. Hong,et al.  Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment. , 2007, World journal of gastroenterology.

[38]  Gerald Holtmann,et al.  Immune activation in patients with irritable bowel syndrome. , 2007, Gastroenterology.

[39]  R. Clouse,et al.  USE OF PSYCHOPHARMACOLOGICAL AGENTS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS , 2005, Gut.

[40]  Gulzar Singh,et al.  Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[41]  Michael P. Jones,et al.  Symptoms, Gastric Function, and Psychosocial Factors in Functional Dyspepsia , 2004, Journal of clinical gastroenterology.

[42]  E. Spitznagel,et al.  The presentation of irritable bowel syndrome in the context of somatization disorder. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[43]  E. Spitznagel,et al.  The Association of Irritable Bowel Syndrome and Somatization Disorder , 2001, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[44]  L. Tanum.  [Functional somatic syndromes]. , 2000, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[45]  R. Lydiard,et al.  Experience with anxiety and depression treatment studies: implications for designing irritable bowel syndrome clinical trials. , 1999, The American journal of medicine.

[46]  B. Naliboff,et al.  Symptom differences in moderate to severe IBS patients based on predominant bowel habit , 1999, American Journal of Gastroenterology.

[47]  G. DeGrandi-Hoffman,et al.  Functional Somatic Syndromes , 1999, Annals of Internal Medicine.

[48]  J A Garcia Regueiro,et al.  Rapid determination of skatole and indole in pig back fat by normal-phase liquid chromatography. , 1998, Journal of chromatography. A.

[49]  P. Whorwell,et al.  The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress , 1997, Alimentary pharmacology & therapeutics.

[50]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[51]  M. Bickel.  The role of interleukin-8 in inflammation and mechanisms of regulation. , 1993, Journal of periodontology.

[52]  M. Ketterer,et al.  Somatization disorder , 1989, The Journal of the American Osteopathic Association.

[53]  Z. J. Lipowski.  Somatization: the concept and its clinical application. , 1988, The American journal of psychiatry.

[54]  R. Spiller,et al.  Bowel Disorders. , 2016, Gastroenterology.

[55]  T. Heinrich.  Medically unexplained symptoms and the concept of somatization. , 2004, WMJ : official publication of the State Medical Society of Wisconsin.

[56]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[57]  Y. Katayama.  Bowel disorders. , 1990, Postgraduate medicine.

[58]  L. Covi,et al.  SCL-90: an outpatient psychiatric rating scale--preliminary report. , 1973, Psychopharmacology bulletin.